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Despite the significant costs related to substance misuse, a small budget is 
allocated to tackling the issue
1. Substance misuse can cause a wide range of harm to the individual, their family and wider 
society. It is estimated that alcohol misuse alone costs up to £900 million per year in Northern 
Ireland, including £250 million of costs borne by the Health and Social Care sector. Despite 
these significant costs, the Department of Health (the Department) allocates a small budget to 
tackling these issues each year, £8 million for implementing its alcohol and drug strategy and 
£8 million towards statutory addiction services.
2. Every day in Northern Ireland, an average of 200 hospital beds are occupied where substance 
misuse was recorded as a contributing factor. The number of bed days occupied where 
there was a primary diagnosis of mental and behavioural issues due to substance misuse has 
increased by over 35 per cent in the last five years. In comparison, in England, these bed days 
have decreased by almost one quarter over the same period.
The level of harm caused by substance misuse is high and rising
3. The numbers seeking treatment for drug misuse have increased significantly from 2,107 in 
2007 to over 4,100 in 2019. Over the same period drug misuse deaths in Northern Ireland 
have increased by more than 200 per cent. Alcohol misuse deaths have increased by more 
than 40 per cent since 2013 in Northern Ireland, more than anywhere else in the United 
Kingdom.
4. Addiction services are facing significant and growing pressures, including the increasing 
complexity of care required, an ageing cohort of service users and co-existing mental health 
issues which make management of treatment more complicated. Services are also under 
increasing strain, in particular where waiting lists for some services have been in excess of a 
year. Whilst this situation has improved, in part due to non-recurrent funding to address the 
issue, there are still a significant number of people waiting to access statutory addiction services 
in Northern Ireland at any given time.
5. Excessive waiting times can deter people from seeking treatment and negatively influence health 
outcomes for service users. The Substitute Prescribing Service has experienced particularly 
long waiting lists, although extra investment has recently reduced these. The Department has 
held a long-standing ambition to share responsibility for this care with primary care, in order to 
normalise care for service users and reduce the pressure on statutory addiction services, but this 
has not been successful.
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6. Residential care has been partly reviewed and regionalised. While this has been broadly 
successful for detoxification and stabilisation, more work is required to ensure that there is 
equitable access to rehabilitation beds, in particular securing access for service users in all 
Trust areas. Referral pathways from statutory addiction services to rehabilitation providers are 
inconsistent and should also be reviewed.
The Department has little information on outcomes for service users
7. The Department’s performance monitoring of substance misuse services is very limited. Data 
collected is not reliable or complete, therefore the Department cannot demonstrate that services 
are effective or delivering value for money for the taxpayer. The Department’s Substance Misuse 
Database has not been published for over two years due to quality issues.
8. The Department has little information on outcomes for service users. The data collected is largely 
activity based, rather than focusing on outcomes. Whilst we acknowledge that this information 
can be difficult to collect, ultimately the Department’s data should focus on the impact services 
have on people’s lives rather than the numbers coming through the door.
Value for Money Conclusion
9. Whilst our audit noted some cost effective initiatives aimed at reducing the harms related to 
substance misuse, the Department has little reliable information on the outcomes for service 
users. It is therefore not possible to determine whether public funding spent on addiction services 
provides value for money or whether service users are getting the best possible outcomes.
Scope
10. Our investigation has focused on the services delivered by healthcare providers to those 
affected by drug and alcohol misuse. However, it is clear from our work that a joined up 
approach encompassing the whole of government is required to fully tackle this issue.
11. This report was completed before the outbreak of COVID-19.  To ensure that audit work did 
not disrupt the efforts of severely stretched public bodies dealing with a most challenging set of 
circumstances, the NIAO took a conscious decision not to publish during the pandemic even 
though the report had been finalised.
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Part One:
Introduction
1.1 Substance misuse can cause a wide range of harm to the individual, their family and wider 
society. This can impact on the individual’s physical and mental health, unemployment, 
homelessness and criminal activity. There are also high economic and human costs associated 
with substance misuse.
1.2 Substance misuse is a complex issue and does not occur in isolation. Many factors contribute to 
substance misuse and related harms. Recovery involves more than helping people to overcome 
their dependency. It includes addressing a range of needs which are critical in supporting 
people to progress towards and maintain a life free from substance misuse. Service users 
may need support with housing, family and relationships, employment and the criminal justice 
system.
Substance misuse results in significant costs to the public sector and 
wider society
1.3 In 2009, the Department of Health (the Department) estimated that alcohol misuse costs around 
£680 million per annum in Northern Ireland. This includes £171 million of direct health and 
social care costs; £224 million of fire & rescue and police service costs; £84 million of courts 
and prisons costs; and £202 million of costs to the wider economy (see Figure 1). Estimates by 
the Department suggest that costs may have risen to £900 million per annum by 2014, £250 
million of these borne by the Health and Social Care sector.  To date there are no equivalent 
estimates for the costs of drug misuse in Northern Ireland.
Figure 1. Alcohol misuse results in significant costs
In 2009, the Department estimated that alcohol misuse in Northern Ireland costs around
£680 million per year.  Around one quarter of these costs fell directly on the health and 
social care system.
Costs to the wider economy include absenteeism
at work, unemployment and premature mortality
Police and fire services
£224 million
Wider economy
£202 million
Health and 
social care
£171 million
Courts and
prison service
£84 million
Source: Department of Health
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1.4 Substance misuse also imposes substantial costs on other parts of the public sector. The 
criminal justice system, for example, experiences significant costs in dealing with crime and 
court proceedings related to substance misuse. Alcohol related crime makes up a substantial 
proportion of violent offences in Northern Ireland. It was a contributing factor in just over 
14,000 offences in 2018-19, around 40 per cent of all violent crime.1
1.5 The Department estimates that £224 million per annum is incurred by the fire & rescue and 
police services dealing with alcohol related callouts and crime, whilst costs to the courts and 
prison services were estimated to be more than £83 million per annum, including the costs of 
legal aid, public prosecution costs and the costs of prisoners serving custodial sentences for 
alcohol related crimes.2 The Police Service of Northern Ireland (PSNI) reports that drug seizure 
incidents have increased by almost 50 per cent in the five years to March 2019, with over 
7,000 seizures in 2018-19, the highest level ever recorded in Northern Ireland. Drug related 
arrests have also increased significantly over the last five years.
1.6 Substance misuse also generates a range of cost impacts in the wider economy. The 
Department estimated that over £200 million per annum of alcohol related costs are incurred by 
the wider economy, including the costs of absenteeism at work, unemployment and premature 
mortality due to alcohol related conditions. 
1.7 Despite these significant costs to the public sector, a relatively small budget is allocated to 
tackling the problem by the Department of Health. In terms of direct funding, the Department 
allocates £8 million per annum for implementation of the New Strategic Direction for Alcohol 
and Drugs. It also allocates £8 million per annum for statutory addiction services from the 
mental health budget, representing 5 per cent of the total mental health budget. 
The level of harm caused by substance misuse in Northern Ireland is high 
and rising
1.8 Whilst alcohol remains the substance that causes most deaths locally, the level of drug related 
harm has increased significantly in Northern Ireland over the last decade. The number of drug 
related deaths has more than tripled from 53 in 2008 to 161 in 2018 (see Figure 2). 
1 Police Recorded Crime Statistics in Northern Ireland 1998-99 to 2018-19
2 DHSSPS, Social Costs of Alcohol Misuse in Northern Ireland (2008/09)
8 Addiction Services in Northern Ireland
Part One:
Introduction
Figure 2. The number of deaths due to drug misuse increased by over
230 percent between 2007 and 2018
Source: NISRA
2007 2018
150
100
50
DEATHS PER YEAR
200
1.9 Some of the largest health inequality gaps in Northern Ireland are related to alcohol and drugs. 
In the most deprived areas alcohol and drug related deaths are around four and a half times 
the rates seen in the least deprived. Alcohol and drug related hospital admissions reflect similar 
inequalities. In the most deprived areas admissions are around four times the rate than in the 
least deprived areas. Some of the largest inequalities are in the Belfast Trust area (see Figure 3).
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Figure 3. Some of the largest health inequalities related to drugs and
alcohol are seen in the Belfast Trust area
Source: Department of Health, Health Inequalities Annual Report 2019
Hospital admissions per 100,000 population
Deaths per 100,000 population
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Alcohol related
admissions
Drugs related
admissions
Alcohol related
deaths
Drugs related
deaths
NI Average Rate in the most deprived area of Belfast
1.10 The numbers presenting for substance misuse treatment have increased significantly in the last 
decade, although this is likely to underestimate the scale of the problem. At 30 April 2019, 
6,743 people were in treatment3 for substance misuse. This represents an increase of 21 per 
cent since 2007 and 13 percent over the last two years. 
1.11 Whilst demand for services has increased, the majority of this relates to people seeking 
treatment for drug misuse (see Figure 4). In 2019, there were 4,183 people in treatment for 
problem drug use, compared to 2,107 in 2007, an increase of more than 98 per cent over 
the period.4
3 The number of people in treatment is defined as “live cases” where individuals are being seen on a one-to-one basis. 
4 Census of Drug and Alcohol Treatment in Northern Ireland, Department of Health, (September 2019).
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Drugs
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Figure 4. There has been a significant increase in the proportion of
people who present for drug misuse treatment  
Source: Department of Health
2007:
5,583
presentations
2019:
6,743
presentations
20% 18% 62%
33% 29% 38%
Whilst alcohol misuse remains the most prevalent substance issue in Northern 
Ireland, the nature of drug misuse is changing
1.12 Addiction services have witnessed a significant escalation in the demand for drug misuse 
treatment, in particular treatment relating to heroin use. Patterns of drug use have also changed, 
with the misuse of prescription drugs and polydrug misuse5 being significant factors.
1.13 Misuse of prescription drugs means taking a medication in a manner or dose other than 
prescribed, taking someone else’s prescription, or taking a medication to feel euphoria. 
Prescription drug misuse can have serious medical consequences including the risk of overdose 
and addiction. There are a number of prescription drugs that are particularly susceptible to 
misuse and appear to contribute to drug related harm in Northern Ireland. The changing nature 
of drug misuse is discussed further in Part Three.
5 Polydrug use is when a person uses more than one type of drug, either at the same time or at different times. Polydrug use 
occurs when a person:
• uses two or more drugs in combination
• uses one drug to counteract the effects (or the after effects) of another
• uses different drugs at different times over a short period of days or weeks.
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The strategy for reducing the harm related to alcohol and drug misuse is due to 
be updated 
1.14 The Department has overall strategy development and evaluation responsibility for alcohol 
and drugs and launched its New Strategic Direction for Alcohol and Drugs (NSD) Phase 2 
2011-16 in March 2012. The strategy sets out a number of objectives in relation to substance 
misuse in Northern Ireland. The original NSD covered the five-year period 2006-2011, but 
the Department considered this too short a timeframe to have a significant impact and so the 
strategy was revised and extended to 2016.
1.15 The Department reviewed the strategy in 2018 and published its findings in early 2019. The 
review concluded that:
• Whilst progress had been made on a number of population level indicators, the pressure 
on services, specifically the demand for Substitute Prescribing Services, and increases in 
alcohol and drug related deaths, were of particular concern.
• Data from the Impact Measurement Tool (IMT) did not meet the requirements for publication 
as an official statistic and data quality issues remain (see Part Five). 
• The gap between finalising the strategy and procuring services meant that there had been 
little time for new services to become embedded and make a real difference to individual 
and population level outcomes.
1.16 The Department told us that it has completed a pre-consultation exercise seeking views on what 
should be included in any new substance misuse strategy and established an advisory group 
including representatives from the Department, service users, the Department of Justice/PSNI, 
the Public Health Agency (PHA), the Health and Social Care Board (HSCB), the Drug and 
Alcohol Co-ordination Teams, and the NI Alcohol and Drug Alliance. This work was originally 
due for completion by the end of September 2019, with findings shared with the NSD Steering 
Group by December 2019.
There are a number of bodies involved with alcohol and drugs services in 
Northern Ireland
1.17 Substance misuse services are structured in four tiers, in line with guidance provided by the 
NHS (see Figure 5). In Northern Ireland, lower tier services are normally commissioned from the 
voluntary and community sector, whilst interventions that are more intensive are procured from 
the Health and Social Care Trusts (the Trusts), usually through the Community Addiction Teams. 
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Tier 4
Tier 3
Tier 2
Tier 1
Residential specialised treatment, detox, stablisation
and rehab
Moderate to severe issues.  Community Addiction Teams,
psychological and pharmacological interventions
including substitute prescribing. Commissioned by 
HSCB and primarily delivered by the Trusts
Early/brief intervention services. Commissioned by
the PHA and mostly delivered by voluntary/
community organisations
Universal services/low threshold services.
Commissioned by the PHA and usually
delivered by a voluntary or community
organisation, although Trusts do some 
outreach work
Figure 5. Substance misuse services are structured in four tiers
Source: Department of Health
4
3
2
1
1.18 Whilst the Department has overall responsibility for strategy development, the PHA provides 
expert advice to the Department; commissions services at Tiers 1 and 2 and supports the five 
local Drug and Alcohol Co-ordination Teams (DACTs) aligned to Trust areas. The HSCB is 
responsible for commissioning services at Tiers 3 and 4. There is an NSD Steering Group, 
chaired by the Chief Medical Officer, which is responsible for policy oversight and strategy 
delivery and monitors overall progress against the NSD’s targets and outcomes. 
Part Two:
Costs of Substance Misuse
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The health sector incurs significant costs dealing with alcohol and drug misuse
2.1 It is estimated that approximately 25 per cent of Accident and Emergency (A&E) department 
consultants’ time is spent dealing with alcohol related incidents6, with figures as high as 75 per 
cent being reported at peak times. Whilst some A&E attendances are one-offs, there is a small 
group of people who repeatedly present at A&E and account for a disproportionate level of 
hospital use and associated costs.
2.2 In 2018-19 there were 822,847 new and unplanned attendances at A&E departments in 
Northern Ireland7. Using the NHS reference cost of an A&E attendance (£160), and assuming 
a quarter of these were alcohol related, we estimate the cost of A&E attendances relating to 
alcohol misuse in Northern Ireland in 2018-19 to be almost £33 million. 
2.3 In 2017-18 there were over 14,600 admissions to Northern Ireland hospitals where there was 
a diagnosis of a condition wholly attributable to alcohol or drugs. The vast majority of these 
admissions involved alcohol (88 per cent) and almost 17 per cent involved drugs. Nearly 5 
per cent involved both. At an average cost of over £1,500 per admission, the total cost of 
admissions where alcohol and drug related conditions were recorded was almost £23 million. 
Over 73,000 hospital bed days were occupied where substance misuse was recorded as a 
contributing factor in 2017-18. Whilst the majority of this relates to alcohol, this equates to 200 
hospital beds occupied every day.
Figure 6. Hospital bed days due to mental and behavioural issues
caused by substance misuse have increased by 35% since 2013-14
in Northern Ireland
Over the same period the number of bed days in Wales due to this reason fell by 9%.
Source: NIAO analysis of Department of Health statistics
+40%
-20%
2013-14
BASELINE
In Northern Ireland there were 9,400
hospital bed days due to disorders caused by
substance misuse in 2017-18 
Over the same period the number of 
bed days for this reason in England
decreased by 25%
2014-15 2017-18 2014-15 2017-18
+20% +20%
-20%
+40%
2013-14
BASELINE
6  Alcohol’s Impact on Emergency Services, Institute of Alcohol Studies (October 2015)
7  Northern Ireland Hospital Statistics: Emergency Care (2018-19)
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Substance Misuse Liaison Nurses can reduce A&E attendances and refer 
patients to specialist addiction services
2.4 Establishing a consultant-led, multidisciplinary Alcohol Care Team (ACT) and specialist alcohol 
liaison nurse services were two of the recommendations of the National Confidential Enquiry8 
into Patient Outcome and Death (2013) ‘Measuring the units: a review of patients who died 
with alcohol-related liver disease’. This study highlighted delays in the referral of patients 
for specialist alcohol care, and missed opportunities for brief interventions during previous 
admissions.
2.5 The Belfast ACT was introduced in 2012, following a review that found over 20 per cent of 
A&E attendees were drinking at a high risk level and 50 per cent at a harmful level. Its role was 
to coordinate alcohol inpatient and outpatient care and develop strategies to reduce alcohol-
related problems within the Trust.
2.6 Guidance from the National Institute for Health and Care Excellence (NICE) recommends 
that all patients admitted to an acute hospital should be offered alcohol screening, and that 
screening of all A&E attenders is highly desirable.  Those patients identified as higher risk 
should be referred to the Substance Misuse Liaison Nurse (SMLN). SMLN services are based in 
all HSC Trusts and also provide brief interventions and advice, along with discharge planning 
and liaison with formal addiction services.  Brief interventions are proven to be successful – 
one study concluded that for every two patients referred to a SMLN there will be one less A&E 
attendance within 12 months.9 
2.7 There are two SMLNs covering the whole of the Belfast Health and Social Care Trust (Belfast 
Trust) area, a population of 340,000 with over 200,000 A&E attendances every year. 
Whilst funding has been made available for two additional posts, the amount of education 
and training provided by the SMLN has reduced significantly and it is not possible to provide 
seven day a week coverage. Patients with substance misuse related morbidity tend to access 
healthcare services on a recurrent basis, providing opportunities for them to be identified and 
referred to specialist addiction services for support. However, a review conducted by the Belfast 
ACT found that only 15 per cent of higher risk drinkers were being referred to SMLN services.  
As a consequence, opportunities to refer patients to appropriate addiction services are being 
lost. 
2.8 The SMLN service is likely to change as a new model for mental health services within acute 
hospital settings is being developed.  The SMLN role is expected to be included alongside 
other mental health professionals covering patients who present with self-harm, substance 
misuse, mental health or psychosocial crisis. There are some concerns that the expertise within 
the SMLN service will be lost when the new model is implemented.
8 National Confidential Enquiry into Patient Outcome and Death (NCEPOD) is an independent body whose purpose is to 
assist in maintaining and improving standards of care by reviewing the management of patients, by undertaking confidential 
surveys and research.
9 Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic 
randomised controlled trial, Crawford, MJ, et al., Lancet. 2004 Oct 9-15;364 (9442):1334-9.
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Recommendation 1
In the context of the reorganisation of mental health services within acute hospital 
settings, the Department should ensure that it continues to raise awareness of substance 
misuse screening and referrals to substance misuse services.
Part Three:
The Changing Nature of Substance Misuse
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Alcohol related harm is on the rise
3.1 Alcohol misuse remains the most prevalent substance misuse issue in Northern Ireland, with the 
most severe impact on health. Alcohol is a causal factor in more than 60 medical conditions, 
including mouth, throat, stomach, liver and breast cancers; high blood pressure, cirrhosis of 
the liver; and depression (see Figure 7).10 A significant proportion of the health issues due to 
alcohol consumption arises from injuries, including those due to road traffic accidents; violence; 
and suicides.
Figure 7. Alcohol misuse contributes to significant health issues
HARMFUL ALCOHOL USE CAUSES
48% of liver cirrhosis
26% of mouth cancers
26% of pancreatitis
18% of suicides
13% of epilepsy
Source: World Health Organisation
3.2 Alcohol misuse can have long term health consequences, resulting in repeated attendances 
at emergency departments, frequent hospital admissions, and long term intensive healthcare 
interventions. Recent reports suggest that one in ten people in a hospital bed are alcohol-
dependent and one in five are drinking at a harmful level.11
3.3 Diagnoses of alcoholic liver disease have also increased sharply in Northern Ireland. In 2011-
12 there were 1,692 admissions at hospitals with a diagnosis of alcoholic liver disease. By 
2017-18 this had increased to more than 2,500, an increase of almost 50 per cent. 
Alcohol-related brain injury presents a significant healthcare challenge
3.4 Alcohol-related brain injury (ARBI) describes the effects of changes to the structure and function 
of the brain resulting from alcohol toxicity and vitamin deficiencies. It is an umbrella term 
covering a range of conditions that share common characteristics – the existence of cognitive 
impairment directly related to chronic alcohol consumption. Studies show that alcohol-related 
brain changes are present in 35 per cent of those with alcohol dependence as opposed to 1.5 
per cent of the general population.
10 The public health burden of alcohol: evidence review, Public Health England (December 2016)
11 Society for the Study of Addiction (July 2019)
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3.5 The cost of dealing with ARBI can be significant, due to acute bed occupancy and frequent 
attendance at emergency departments. In the absence of alternative treatment, ARBI patients are 
often placed in inappropriate and costly dementia care settings within nursing homes. A number 
of projects have been carried out in Northern Ireland to estimate the impact that ARBI has on 
healthcare services.
Case example 1: South Eastern Health and Social Care Trust
In 2016, the gastroenterology service carried out a retrospective review of ARBI cases 
encountered by their service over the previous five years. A random sample of 19 patients 
was selected. For this group, the number of hospital admissions over five years ranged from 
one to 37, with an average of 14.7 admissions per patient, and an average length of stay 
of 21.2 days. The Trust estimated that the average stay cost was £7,165. This equates to 
over £105,000 per person over a five-year period, and a total cost of just over £2 million 
for the 19 patients sampled.
Source: Alcohol-related brain damage in Northern Ireland, Royal College of Psychiatrists (April 
2018)
3.6 ARBI has a relatively good prognosis – up to 75 per cent of patients make an improvement with 
abstinence and appropriate treatment. There is no standard or formal approach to treatment 
for ARBI patients, and no specific ARBI unit exists in Northern Ireland. Many patients end up in 
institutional settings for the rest of their lives. Providing specialist services would allow many of 
these patients to recover sufficiently to be transferred to less supported, and ultimately less costly 
placements. Leonard Cheshire, a charity providing supported living and community based 
services, is developing a new 14 bed facility in Belfast, focusing on residential rehabilitation for 
ARBI patients. This will be the first facility of its kind in Northern Ireland and is due to open in 
March 2020.
Alcohol misuse deaths have increased sharply
3.7 In 2017, 303 of the 16,036 deaths registered in Northern Ireland were due to alcohol related 
causes, the highest number ever recorded. Whilst this number fell to 284 in 2018, it remains 
almost 17 percent more than a decade previously. The number of alcohol related deaths is 
consistently higher among men, accounting for almost 70 per cent of the 2018 total. The 
largest number of alcohol related deaths occurs in those aged between 55 and 64 years.12 
3.8 Alcohol misuse deaths have increased more in Northern Ireland than anywhere else in the 
United Kingdom - in the five years to 2017, alcohol related deaths increased by over 40 per 
cent in Northern Ireland. This is a significantly higher increase compared to the rest of the 
United Kingdom, where increases have ranged from six to nine per cent (Figure 8).
12  Alcohol Related Deaths 2008 – 2018, NISRA.
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Figure 8: Northern Ireland has the second highest rate of alcohol 
related deaths in the UK
2013 2014 2015 2016 2017
Northern Ireland 12.2 12.9 16.4 16.8 17.4
Scotland 19.0 19.5 19.5 21.1 20.5
Wales 12.7 11.5 11.9 12.7 13.5
England 10.2 10.5 10.3 10.5 11.1
Alcohol-specific death rates are expressed per 100,000 people
Source: Office for National Statistics
Prescription drug misuse is a growing issue in Northern Ireland
3.9 There are a number of prescription drugs that are particularly susceptible to abuse and appear 
to contribute to drug related harm (see Figure 9). Many of the drugs that are abused are 
available on prescription, however, there are other means of acquiring them: 
• Taking medication which is prescribed for someone else
• Illegal purchase
Misuse can also involve using medication prescribed to you in a way not intended by the 
prescriber.
Figure 9: There are a number of commonly misused prescription drugs
Diazepam
Diazepam is used to treat anxiety, alcohol withdrawal and seizures. It is also used to relieve 
muscle spasms and to provide sedation before medical procedures. It belongs to a class of 
drugs called benzodiazepines. Benzodiazepines work by slowing down activity in the brain 
and keeping the brain in a more tranquilised state. 
Doctors recommend that patients should not be on these drugs for longer than four weeks 
as tolerance levels can develop causing an increase in dosage which eventually leads to 
addiction problems. Sudden withdrawal can be dangerous resulting in hallucinations and 
convulsions. 
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Tramadol
Tramadol is a strong opioid painkiller used to treat moderate to severe pain, for example 
after an operation or a serious injury. It is also used to treat long-standing pain when weaker 
painkillers no longer work. Tramadol works by blocking pain signals from traveling along the 
nerves to the brain. People who take tramadol for long periods and at high doses eventually 
develop a physical dependence and may experience unpleasant, dangerous withdrawal 
symptoms.
Gabapentinoids
Pregabalin
Pregabalin is an anti-epileptic drug, sometimes also prescribed to treat chronic pain and 
anxiety. It works by decreasing the number of pain signals that are sent out by damaged 
nerves in the body by slowing the impulses across the brain. Pregabalin is also called by the 
brand names Lyrica, Alzain, Lecaent and Rewisca.
Pregabalin can produce feelings of euphoria, relaxation and calmness. It can also increase 
the euphoric effects of other drugs, like opioids and can increase the risk of overdose when 
taken in this way.
Gabapentin
Gabapentin is used to treat epilepsy. It is also taken for nerve pain. Occasionally, 
gabapentin is used to treat migraine headaches.
Gabapentin has similar effects to drugs like benzodiazepines. It can also enhance the 
euphoric effects of other drugs, like opioids, and is likely to increase the risks when taken in 
this way.
3.10 The number of people presenting to substance misuse services who misuse prescription drugs 
is significant –  according to the most recent Substance Misuse Database, one in five service 
users indicated that they took at least one prescription drug. A recent analysis13 suggested that 
prescription opioid use is more prevalent in Northern Ireland than in the rest of the UK. Eleven 
per cent of treatment entrants in Northern Ireland cited ‘other opioids’ as their primary substance 
of misuse compared to 3.2 per cent in the rest of the UK. 
The majority of drug related deaths involve prescription drugs
3.11 The number of deaths linked to prescription drug misuse is rising. These drugs are now involved 
in the majority of drug related deaths14 in Northern Ireland. The two most common drugs to 
feature on death certificates are diazepam and tramadol; however, there has been a rapid 
13 United Kingdom Drug Situation: Focal Point Annual Report 2017, UK Focal Point on Drugs, (March 2017).
14 A drug related death is one where the underlying cause of death recorded on the death certificate is drug poisoning, drug 
abuse or drug dependence.
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 increase in the number of pregabalin related deaths in the last five years (see Figure 10). 
Diazepam was detected in more than 40 per cent of drug related deaths in Northern Ireland 
in 2018.
Figure 10. Deaths related to prescription drug misuse in Northern 
Ireland are increasing
Source: NISRA
2012 2018
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Northern Ireland prescribes more diazepam per capita than anywhere else in 
the UK 
3.12 The number of prescriptions of diazepam in Northern Ireland has been quite consistent over 
the last five years. However the number of prescriptions per capita is significantly higher in 
Northern Ireland than anywhere else in the UK, and there are three and a half times as many 
prescriptions per capita as in England (see Figure 11). 
PRESCRIPTIONS PER CAPITA:
Figure 11. There are three and a half times as many prescriptions of
diazepam per capita in Northern Ireland as in England
Source: NIAO analysis of BSO data
0 0.1 0.2 0.4
Northern Ireland
0.3
England Scotland Wales
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Strong opioids are prescribed more frequently in Northern Ireland than 
elsewhere in the UK
3.13 HSCB guidance on opioid prescribing15 for Northern Ireland recommends that modified 
release morphine is the first line strong opioid for maintenance of pain control. However, 
when compared with other parts of the UK, it is evident that the prescription of morphine as a 
proportion of all strong opioids in much lower in Northern Ireland than other parts of the UK, 
and other strong oral opioids, such as oxycodone and tramadol, are prescribed much more 
frequently.
3.14 Tramadol, a strong oral opioid, was mentioned in 27 drug related deaths in 2018, an increase 
from 20 in 2013. Significantly, tramadol is mentioned more frequently on death certificates in 
Northern Ireland than any other opioid drug, except for heroin (see Figure 12). A high level 
comparison shows that tramadol was mentioned in 14 per cent of drug related deaths in 
Northern Ireland in 2018, compared to just seven per cent in England, Wales and Scotland.
Figure 12. Tramadol is mentioned more frequently on death
certificates than any other opioid drug apart from heroin
NUMBER OF DEATH CERTIFICATES DRUG WAS MENTIONED ON IN 2018:
Source: NISRA
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15 http://www.hscboard.hscni.net/download/PUBLICATIONS/pharmacy_and_medicines_management/correspondence/
Opioid-Prescribing.pdf
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Northern Ireland prescribes more pregabalin per capita than any other part of 
the UK
3.15 Recently, concerns have emerged about the misuse of gabapentinoids, including pregabalin, 
and their role in drug related deaths. Where gabapentinoids are misused, they are often not 
the primary drug of misuse. Those who misuse opioids often use gabapentinoids to achieve 
a quicker high and reduce withdrawal symptoms from other drugs such as alcohol, heroin or 
diazepam. This close association with an already high-risk population increases the risk of 
fatal overdose. The number of pregabalin related deaths have risen sharply in just four years. 
Pregabalin was mentioned in 54 drug related deaths in 2018, an increase from 5 deaths in 
2014.
3.16 Data from the Health and Social Care Board shows that in 2017, 0.28 prescriptions of 
gabapentinoids were prescribed per head of population in Northern Ireland. This rate was 
higher than the rate in both England and Scotland, although lower than that of Wales 
(Figure 13).
Figure 13. Concerns are increasing about the misuse of pregabalin
In recent years there has been growing concern about the misuse of gabapentinoids
and their role in drug related deaths.  
Northern Ireland has the second highest rate of
gabapentinoid prescription in the UK, but the highest
rate of pregabalin prescriptions
PRESCRIPTIONS PER CAPITA:  
Despite consistent warnings about the dangers of
pregabalin, the number of prescriptions has 
increased over the last five years
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3.17 Whilst pregabalin and gabapentin have similar therapeutic effects, gabapentin is more slowly 
absorbed. NHS advice indicates that pregabalin is relatively more dangerous than gabapentin 
in high doses16. Pregabalin appears to be more sought after for misuse than gabapentin.
16 http://www.hscboard.hscni.net/download/PUBLICATIONS/pharmacy_and_medicines_management/correspondence/
Opioid-Prescribing.pdf
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 In Northern Ireland, more pregabalin is prescribed per capita than any other part of the United 
Kingdom (see Figure 13).
3.18 In November 2012, HSCB wrote to all GPs and community pharmacists in Northern Ireland 
highlighting the potential for misuse of pregabalin and advising “caution should be exercised 
when prescribing to patients with a history of substance abuse”. HSCB issued a further letter in 
October 2016 highlighting increasing risks associated with pregabalin use, increasing volumes 
in usage and providing practical steps to be taken in respect of minimising potential misuse 
of pregabalin. GPs were asked “to be extra vigilant in their initiation, repeat prescribing and 
review of pregabalin.”
3.19 Despite these repeated warnings, prescriptions of pregabalin in Northern Ireland have 
continued to rise. Just over 230,000 prescriptions for pregabalin were issued in 2013; by 
2017 this had increased to more than 300,000 (Figure 13). This represents an increase of 
over 32 per cent. 
3.20 As a result of these concerns and as a means of reducing abuse, the Advisory Council on the 
Misuse of Drugs (ACMD) recommended that pregabalin and gabapentin should be controlled 
as Class C Drugs under the Misuse of Drugs Act. Following a public consultation, pregabalin 
and gabapentin were reclassified as Class C controlled substances in April 2019. The change 
means it is illegal to possess pregabalin and gabapentin without a prescription and it is illegal 
to supply or sell them to others.
The complexity of care required has changed significantly
3.21 Those seeking treatment for substance misuse are increasingly using more than one drug or type 
of drug. Polydrug misuse encompasses the use of both illicit drugs and legal substances such 
as alcohol and medicines. Almost 60 per cent of those presenting for treatment use more than 
one type of drug, with a quarter of service users reporting use of more than four types of drug17. 
The use of multiple drugs potentially increases the risk of fatal and non-fatal overdose and 
worsens dependence. Nearly three quarters of drug related deaths in 2018 involved the use of 
more than one type of drug. The management of polydrug misuse is a complex and challenging 
task for treatment providers and is often less successful for those who use multiple substances. 
3.22 Substance misuse services are also dealing with an ageing cohort of service users, who come 
with a range of health, social and economic challenges. Almost one third of those presenting 
for substance misuse treatment in Northern Ireland are over the age of 4518, and over 85 per 
cent of alcohol specific deaths in 2017 occurred in this age group. Illnesses such as dementia, 
diabetes and hypertension, in combination with substance misuse issues, mean that intense and 
complex care is often required. 
17 NI Substance Misuse Database (2016-17). Whilst figures detail the use of multiple drugs, they do not discern if these drugs 
were consumed in combination.
18 NI Substance Misuse Database (2016-17)
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3.23 It is very common for people to experience problems with their mental health and substance 
misuse issues at the same time. Evidence suggests that mental health problems are experienced 
by the majority of drug and alcohol users in community substance misuse treatment19.  Co-
existing mental health and substance misuse issues can make management of treatment more 
complicated.  
Recommendation 2
In planning the forthcoming strategy for alcohol and drugs services, we recommend that 
the Department includes the complex and long-term care needs of service users. Failing 
to plan for these needs will result in an increased burden on services, which are already 
facing significant pressures.
19 Better care for people with co-occurring mental health and alcohol/drug use conditions, Public Health England (June 2017)
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Harm reduction services are cost effective 
4.1 Substance misuse services are structured in four tiers, in line with NHS guidance (see Figure 5).  
Tier 2 services encompass lower dependency, early intervention and prevention. The Alcohol 
and Drug Commissioning Framework for Northern Ireland 2013-16 sets out the commissioning 
priorities for addressing alcohol and drug misuse and provides detail on the role and function 
of interventions across the four tiers of service delivery. It also describes the evidence base 
outlining what is effective in addressing alcohol and drug related harm.
4.2 The Commissioning Framework requires that low threshold services should be available for 
those who misuse alcohol and drugs, but are unwilling or unable to access formal treatment 
services. Harm reduction interventions such as needle exchange, information on safer injecting 
and preventing overdose should be locally available.
4.3 Tier 2 services are provided by voluntary and community sector organisations following a 
competitive tender process, with the exception of the Southern Health and Social Care Trust 
(Southern Trust), which provides most of its Tier 2 services in-house. There are a number of 
successful harm reduction and early intervention projects.
Case example 2: Needle and Syringe Exchange
The Needle and Syringe Exchange Scheme provides free, sterile injecting equipment to 
people who inject drugs. The service also provides disposal facilities for used injecting 
equipment. This reduces the risk of spreading blood borne viruses such as HIV and hepatitis 
B and C. It also offers confidential advice and support and helps people to access other 
support services such as housing or other health and welfare services.
In 2018-19, there were 21 pharmacy-based schemes and 2 Trust-led schemes across 
Northern Ireland. The PHA funded £197,000 in needle exchange equipment and 
£103,000 in community pharmacy payments. The number of visits to the service has 
increased by over 30 per cent in the last five years, to over 30,000 in the 12 months to 31 
March 2018. Although there have been challenges in seeking the expansion of the scheme, 
it is anticipated that further sites will be identified.
Case study 3: Take Home Naloxone
Naloxone is a medication designed to rapidly reverse opioid overdose. The Take Home 
Naloxone programme was introduced in 2012 and is available to anyone at risk of opiate 
overdose, through Trust addiction services or the Prison Service. In the first five years of the 
programme, Naloxone was administered 122 times and was successful in reversing an 
overdose on 98 occasions. For each successful overdose reversal, £244 was spent on 
medication. In contrast, an accidental drug overdose typically requires two days in hospital 
and the average cost of a drug related admission is over £1,000.
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Case study 4: Alcohol and You
Launched in October 2013, Alcohol and You was a range of services delivered by the 
South Eastern Health and Social Care Trust in partnership with a number of voluntary and 
community organisations to reduce alcohol related harm. The project received £1.26 million 
of funding, over four years, as part of the Big Lottery Fund’s Impact of Alcohol programme. 
The services available included community based brief intervention clinics provided by 
ASCERT for adults willing to look at their drinking levels or those affected by someone else’s 
drinking. Up to four sessions were available to:
• Assess alcohol use;
• Build motivation to change;
• Engage in brief interventions; and
• Refer on to other services if required.
Outcomes showed that 95 per cent of service users had reduced their alcohol consumption 
on exit from the clinics. Alcohol screening test scores reduced from an average of 19.8 
(harmful drinking) to 8 (lower levels of hazardous drinking). 
Recommendation 3
There is clear evidence that harm reduction projects are a cost effective way of tackling 
the harms related to alcohol and drug misuse. The Department should ensure the further 
development of cost effective harm reduction initiatives as part of the new alcohol and 
drugs strategy.
Links between Tier 2 and Tier 3 services are improving
4.4 The Commissioning Framework requires pathways between Tier 2 and Tier 3 services, however 
a number of voluntary and community groups told us that statutory services have been hesitant 
to refer service users to them. They considered that this was partly due to the short-term nature 
of funding available to voluntary and community groups, meaning that there are lots of “new” 
projects and people involved in delivery. Some groups also referred to a lack of trust in 
voluntary and community services amongst the statutory sector. They highlighted the need to 
build a better understanding of the work done by voluntary and community sector organisations 
and increase confidence in their services. The Department told us that PHA had developed 
a framework document jointly with the voluntary and community sector and Tier 3 services to 
establish links and referral pathways.
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4.5 We heard about initiatives to enhance links between Tier 2 and Tier 3 services:
• The Belfast Trust has established an Addiction Hub, providing clinical triage to determine 
whether Tier 2 or Tier 3 is the correct treatment pathway. Prior to its implementation, the 
Belfast Trust estimated that one third of referrals to Tier 3 Community Addiction Teams 
services were more suitable for treatment at Tier 2 community and voluntary services. The 
aim of the Addiction Hub is to get service users to the right place, early in their treatment 
journey and to avoid the need to tell their story repeatedly. Feedback from service users 
has been positive, and the Belfast Trust told us that working relationships with voluntary and 
community sector colleagues have become closer. This has also reduced pressure, including 
waiting lists for Community Addiction Teams.
• The Southern Trust is developing a Well Mind Hub to raise awareness of its Tier 2 
service with GPs. The intention is to give GPs options and tools to get people to the most 
appropriate treatment sooner. The Southern Trust also aims to increase the legitimacy of Tier 
2 services with primary care providers.
• In the South Eastern Health and Social Care Trust, the Simon Community does outreach 
work with service users. This work is particularly effective for those not engaging with 
treatment services or those who may need support to maintain their engagement.
4.6 Whilst some voluntary and community sector providers welcomed these initiatives as positive 
steps towards collaborative working, they also voiced concerns around a number of issues:
• A continuing lack of awareness of the substance misuse services provided by voluntary and 
community organisations, particularly amongst GPs;
• Different screening or assessment tools used in Tier 2 and Tier 3 services, leading to 
inconsistent referrals to services; and
• Increasing waiting lists for Tier 2 services. In one Trust area, waiting lists for some services 
are around 14 weeks. Whilst the PHA has provided funding to address waiting lists, this is 
a short term solution.
Recommendation 4
In developing its new alcohol and drugs strategy the Department should explore means 
of enhancing relationships between the statutory sector and Tier 2 service providers in 
the community and voluntary sector.
Addiction Services in Northern Ireland 31
Tier 3 addiction services face a number of pressures
4.7 The HSCB commissions Tier 3 addiction services, which are primarily delivered by the Trusts. 
Tier 3 services deal with moderate to severe addiction issues and include:
• Specialised drug and alcohol assessment, management and treatment;
• Addiction Day Treatment;
• Substitute Prescribing; and
• Specialist liaison services.
 Community Addiction Teams sit within Tier 3 and provide support for GP supervised, home 
detoxification as well as advice and support for harm reduction and relapse prevention. 
4.8 Access to Tier 3 is normally as a result of referral from a GP or other health professional. A 
number of Community Addiction Teams told us that GPs often refer patients to Tier 3 initially, 
rather than using Tier 2 services, even when these lower threshold interventions might be more 
appropriate. A number of reasons were suggested for this, including a lack of awareness of the 
services provided at Tier 2. GPs have a very short timeframe to make the referral decision and 
may feel that Tier 3 services are “safer” in terms of governance arrangements and structure, as 
they are provided by the statutory sector. 
4.9 Community Addiction Teams told us of the importance of getting the referral “right first time”, 
as there is a short window of opportunity to get people to engage with services when they are 
most motivated. In our view, further work is required to ensure that the referral process is efficient 
and that people can access support quickly. In particular, greater awareness of substance 
misuse is needed amongst GPs so that people can be referred and signposted to the most 
appropriate services for their needs.
Recommendation 5
The Department should review the referral process and pathways for access to Tier 3 
services, and focus on reducing inappropriate referrals. Raising awareness of addiction 
services amongst primary care providers should form an important part of this review.
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There are often prolonged waiting times for Tier 3 services
4.10 Ministerial targets have been set for the maximum amount of time that people should expect 
to wait for an appointment with various health services in Northern Ireland. These targets are 
determined annually within the Health and Social Care Commissioning Plan Direction for 
Northern Ireland. Mental health waiting time targets apply to addiction services, meaning that 
no service user should wait more than nine weeks from referral to an initial appointment. A 
number of Trusts have struggled to meet these targets in recent years (Figure 14). During the 
course of our review, we spoke to Community Addiction Teams from all five Trusts. Without 
exception, they told us that the number of referrals to addiction services is increasing and that 
they are struggling to keep pace with the level of demand.
4.11 Whilst an increase in referrals might indicate a positive step, in that more people are seeking 
treatment, it can lead to significant difficulties in effective service delivery. In July 2019, over 
1,100 people were waiting for a first appointment with Tier 3 addiction services across 
Northern Ireland, although this had been in excess of 1,600 between August and October 
2017. During the same period in 2017, around one quarter had been waiting for more than 
nine weeks for an appointment.
Figure 14. Trusts have struggled to meet waiting time targets for
addiction services
The waiting time target is that service users should not wait more than nine weeks from
referral for an initial appointment.  Whilst there have been recent improvements, Trusts
have found it difficult to meet this target.
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Over the period under review, the South Eastern Trust consistently met the target.
Source: HSCB
400
Addiction Services in Northern Ireland 33
4.12 Northern Ireland waiting time targets for substance misuse services are longer than the targets 
across the rest of the UK. Furthermore, Northern Ireland is the only region that does not publish 
separate statistics on waiting times for access to substance misuse services (Figure 15).
4.13 Waiting times are important to service users and a high profile measure of how services are 
responding to demand. Long waiting times can be a deterrent for people seeking treatment, 
and can contribute to increased dropout rates prior to treatment. Waiting times can also 
negatively influence health outcomes, prolong risky drug using behaviours and increase the 
potential for involvement with the criminal justice system.
Figure 15: Northern Ireland waiting time targets are considerably 
longer than the rest of the UK
TARGET OUTCOME
England 3 weeks from first being identified 
as having a treatment need to being 
offered an appointment to start an 
intervention
98% offered an appointment within 
3 weeks (year ended 31 March 
2018)
Wales Treatment started within 20 
working days of referral
91.1% (quarter ended 31 December 
2018)
Scotland 90% of those referred start treatment 
within 3 weeks
93.9% (quarter ended 31 December 
2018)
Northern 
Ireland
9 weeks from referral to initial 
appointment
Not published, however HSCB 
statistics show 2.9% waiting more 
than 9 weeks at 31 July 2019
Source: Public Health England; StatsWales; ISD Scotland; and the HSCB.
Since the introduction of substitute prescribing in 2004, there has been a 
significant increase in demand 
4.14 Substitute Prescribing Services (SPS) offer medical treatment for opioid dependency. Opioid 
Substitution Therapy (OST) involves replacing an opioid, such as heroin, with a longer acting 
but less euphoric opioid. Commonly used drugs for OST are methadone or buprenorphine 
which are taken under pharmacists’ supervision. Research shows that participation in OST 
reduces the risk of death by overdose20, reduces the risk of HIV transmission21and reduces 
participants’ involvement in property crime22. OST can be used short term or longer term, 
though long term treatment is likely to produce better outcomes, especially when combined with 
psychosocial interventions.
20 Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study’, 
Clausen T, Anchersen K, and Waal H (2008)
21 Interventions to reduce HIV transmission related to injecting drug use in prison, The Lancet Infectious Diseases, Jürgens R, Ball 
A, and Verster, A (2009)
22 ‘What caused the recent drop in property crime?’ Crime and Justice Bulletin, Moffatt, S., Weatherburn, D., Donnelly, N. 
(2005)
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4.15 Since the introduction of the SPS in 2004, there has been a significant increase in referrals and 
service users (see Figure 16). Substitute prescribing is a long-term harm reduction strategy, and 
over 43 per cent of current service users have been receiving treatment for over five years.23 
A number of the Community Addiction Teams we spoke to during the course of our audit 
referred to the significant and ongoing increase in substitute prescribing caseloads, expressing 
a concern that these are becoming too large to manage safely. One Team Leader told us that 
there were two key workers24 managing almost 100 OST service users in their Trust area. 
In another area, some generic therapists have taken on OST caseloads to ease pressures; 
however they told us that this is not sustainable and can lead to gaps and pressures elsewhere 
in the service.
Figure 16: Substitute prescribing has increased by over 50 per cent
2011 2012 2013 2014 2015 2016 2017 2018
Service users in 
treatment at 31 March
552 627 648 687 738 778 802 845
Total service users seen 
in year to 31 March
639 720 755 822 865 922 944 984
Source: Northern Ireland Substitute Prescribing Database Report 
4.16 The Belfast Trust in particular experienced a substantial spike in referrals to its Substitute 
Prescribing Service resulting in significant waiting times for treatment. At the end of 2016, 
the average waiting time was 47 weeks. By November 2017, waiting times from referral 
to assessment had reached a high of 57 weeks. The Trust told us that this was caused by 
increased in demand, staff shortages in the SPS service and recruitment problems, which made 
it unsafe to induct new patients.
4.17 The Belfast Trust undertook a number of steps to reduce its waiting lists. In addition to the 
traditional keyworker system, the Trust introduced a clinic model for the review and ongoing 
management of individuals stabilised on OST. This additional service model has allowed 
patient flow through the system, creating capacity for intensive one-to-one keyworking at the 
assessment and early to mid-treatment stages and for ongoing complex patients. Waiting times 
have reduced as a result of this introduction. In addition, the Belfast Trust has recruited a non-
medical prescriber and moved to caseload weighting whereby the non-medical prescriber 
carries a larger caseload of more stable patients. The Trust continues to work with GPs to move 
appropriate patients to shared care. The Belfast Trust told us that referrals to SPS have increased 
by around 300 per cent in the last year, and that demand for the service constantly exceeds its 
capacity.
23 Substitute Prescribing Database Report (2017-18)
24 A key worker is a specialist addiction worker who is assigned to a service user and works with them to develop a care 
plan, as well as providing other support including help with access to other medical services and housing support.
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Implementation of a shared care model has not been successful
4.18 Since its inception in 2004, the main principle of the Northern Ireland model for substitute 
prescribing is that it should operate on the basis of shared care25. Shared care encompasses 
the statutory addiction services, primary care, local pharmacies, voluntary addiction services 
and any other agencies who may be involved in providing care and support. Under the shared 
care model, service users who are stabilised should be transferred to GPs for “a significant part 
of their care and prescribing”. 
4.19 Community Addiction Teams also told us that delivering SPS in a primary care setting is 
an important step in normalising treatment for the service user, often much closer to home. 
However, the vast majority of prescribing responsibility in Northern Ireland remains with 
specialist services within the Trusts (see Figure 17). The Northern Health and Social Care Trust 
(Northern Trust) has the highest percentage of service users whose prescribing responsibility is 
shared with GPs at 30 per cent. No other Trust has more than 15 per cent of its service users 
under the care of their GP.
Source: Northern Ireland Substitute Prescribing Database
Figure 17. The majority of prescribing responsibility remains with
Trusts
Under the shared care model the expectation is that GPs should be responsible for “a 
significant part” of providing care and prescriptions for stabilised service users.
However, the majority of prescribing responsibility at 31 March 2018 remained with
HSC Trust specialist services.
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4.20 The Department told us that it is continuing to work to revise the SPS model, particularly towards 
a shared care model, supported by specialist addiction services.  Whilst we acknowledge 
that providing a substitute prescribing service is a personal choice for GPs, and that additional 
training is required, in our view the shared care model presents an important opportunity to
25 http://www.emcdda.europa.eu/attachements.cfm/att_231383_EN_UK27_niguide_substitute_treatment.pdf
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 transition service users to community based care, and could therefore ease the significant 
pressure on Community Addiction Teams. 
Recommendation 6
The Department should consider the viability of extending the shared care model for 
substitute prescribing.
4.21 The HSCB and PHA acknowledge that “the increasing complexity of problems, changes in drug 
using trends and increased levels of referrals to treatment services have led to critical service 
pressures within Tier 3, including unacceptable delays in accessing treatment”. As a result 
of these pressures they appointed a review team to undertake a “comprehensive review…to 
guide the future development of Tier 3 service delivery regionally.” The review comprises two 
elements, a focused review of SPS services, followed by a wider review of Tier 3 addiction 
services.
4.22 The Department told us that a draft report has now been written, and action plan is being 
prepared. This includes the need for action to increase shared care participation and 
establishment of a regional project to address the review’s recommendations which include 
variation in practice and greater consistency.
Residential detoxification and stabilisation services have been restructured 
4.23 Although most treatment can be safely undertaken within the community Tier 3 setting, a small 
number of individuals with more complex needs, who are higher risk or more vulnerable, may 
not respond to community based care. Access to Tier 4 inpatient based addiction treatment is 
required in these cases. NICE guidelines recommend that inpatient treatment should encompass 
both initial detoxification and stabilisation (Tier 4a) followed by rehabilitation and support (Tier 
4b). Prior to 2014, there were 42 inpatient beds within the Health and Social Care sector, with 
considerable variation between units. For example, some units operated on a part time basis, 
some focused upon detoxification while others focused on rehabilitation. Detoxification and 
stabilisation services were available to residents from the Northern, South Eastern and Southern 
Trust areas, but there was no access to these services for residents of either the Belfast or 
Western Trust. Two independent sector organisations provided rehabilitation services in Belfast 
and Derry/Londonderry. 
4.24 The Health and Social Care Board reviewed inpatient based addiction treatment services 
in 2013 with the aim of reconfiguring services in order to provide a more consistent and 
regionally agreed service model that could be accessed by all residents of Northern Ireland. 
The new model encompassed three medically managed detoxification wards (Tier 4a) across 
three regional sites, managed by the Trusts. Tier 4b services were not considered as part of this 
review.
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Residential care requires more coordination
4.25 Tier 4a has capacity for 500 in-patient stabilisation/detoxification episodes per year. These 
are provided at Trust sites in Antrim, Omagh and Downpatrick. Access to Tier 4a is by referral 
from Tier 3 Community Addiction Teams. These Teams told us that the three Tier 4a sites are 
currently able to cope with the level of demand and that the waiting time for inpatient treatment 
is around four weeks. The 2013 review recommended that the number of Tier 4a beds should 
be reviewed by 2019, in light of changing population trends and needs. To date, no further 
review has been undertaken. 
4.26 The review of Tier 4 services considered that more coordination was needed including the 
“development of a regional coordination role to ensure that inpatient and residential access is 
managed on patient need and priority”. It also recommended the establishment of a Regional 
Addiction Treatment Network (RATN) encompassing all Trusts and commissioned independent 
sector providers to oversee and manage Tier 4 arrangements across both sectors. The aim was 
to ensure that people from all Trusts areas could access Tier 4 care, regardless of where they 
lived.  This regional coordinator role no longer exists, and the RATN has not met for over 18 
months.
Recommendation 7
We recommend that a review of Tier 4a detoxification and stabilisation beds is 
completed to assess whether the number of beds is sufficient. We also recommend that 
the Department ensures that there is adequate oversight and coordination in place to 
manage access to beds on a regional basis.
Access to residential rehabilitation is not consistent 
4.27 Tier 4b rehabilitation services were not the focus of the original review in 2013. In its review, 
the HSCB acknowledged there was considerable variation between Trust areas and that a 
“more consistent and regionally agreed approach is clearly required”. The HSCB proposed a 
number of actions points in respect of Tier 4b services, which included: 
• The HSCB would closely monitor demand for rehabilitation care, and working with the 
independent sector, would increase service provision as required; and
• All Trusts should be able to access Tier 4 rehabilitation care from the existing independent 
sector providers. Access to these providers would become available, in due course, to all 
Trust areas. 
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4.28 Ultimately, the existing service model was retained in Northern Ireland, with capacity for 200 to 
300 residential rehabilitation episodes per year, provided by two independent sector providers. 
Under the existing model, the Southern and South Eastern Trusts do not have formal access to 
rehabilitation beds, meaning that most patients are treated in the community instead, even when 
inpatient treatment may be the most suitable approach. 
4.29 The Commissioning Framework states that the Tier 4 service model must encompass a number 
of specific functions, including opioid substitution programmes. However, one rehabilitation 
provider does not accept residents who are receiving opioid substitution therapy, as it follows 
an abstinence based model.  As a result, referrals to this provider from Tier 3 statutory addiction 
services are very low, and most residents have referred themselves for treatment. The majority of 
referrals to the other provider come from the Community Addiction Teams, however it is required 
to hold a small number of beds for referrals from GPs. This provider told us that it is advocating 
for the removal of these GP beds, as the unplanned discharge rate for these residents is 
significantly higher than for those referred by the Community Addiction Teams.
4.30 Aftercare planning is particularly important for those who have undergone detoxification or 
rehabilitation. Service users are more vulnerable to overdose in the period following discharge 
if they return to substance misuse. Despite this risk, arrangements for aftercare and support are 
inconsistent across Tier 4b. One provider offers a two-year programme of support, but this is 
not part of its contract with the Trusts and it relies on volunteers to deliver this service. Another 
provider told us that aftercare is the responsibility of the Community Addiction Teams, but that 
the intensity of support varies between Trusts. 
4.31 In our view, residential rehabilitation services are not yet being delivered in a consistent 
regional way. Inconsistent access criteria, the variety of referral pathways, and a lack of access 
to beds mean that the service user journey can be fragmented and access to appropriate 
treatment is often delayed. 
Recommendation 8
Regionalisation of Tier 4 has not been extended to residential rehabilitation services. 
We recommend that a review of Tier 4b is completed to assess the level of demand for 
rehabilitation care and determine whether the current number of beds is appropriate. The 
Department should also ensure that all Trusts have formal access to rehabilitation beds, 
with consistent referral pathways and access criteria across all providers.
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The Department’s limited performance monitoring means it cannot be sure it is 
getting value for money or delivering effective services
5.1 Assessing the effectiveness of alcohol and drug treatment is challenging because there is no 
definitive cure. Treatment often does not take a defined pathway or end point, and people often 
use services more than once in their lifetime. The Department collects information on substance 
misuse services through a number of methods. The Substance Misuse Database (SMD) is an 
annual summary of people presenting to services with problem drug and/or alcohol misuse. In 
2016, it replaced the Northern Ireland Drug Misuse Database. Information is requested from 
treatment services at all tiers, from both the statutory and voluntary and community sectors. 
5.2 Information collected from service providers stems from the NSD priorities. Only service users 
attending for the first time or those who have not attended for treatment in the previous six 
months are recorded on the SMD. The information collected is largely demographic, for 
example age, gender and location, as well as details on which substances they are seeking 
treatment for. The SMD is not outcomes based, service users are recorded once, at the point of 
entry, and no further information is collected as they continue through treatment.
There are significant issues with data quality and completeness
5.3 Statistics from the first SMD, covering 2016-17, was published in January 2018. However, 
since then issues with data quality have prevented the Department from publishing any further 
statistics. The Department told us that there were significant quality issues with the data received 
from addiction service providers. These included gaps in the information provided by services 
both from statutory and voluntary and community sector providers and comparable data, which, 
in the Department’s view, was incomplete. The Department told us that such was their concern 
with the data quality, they were unable to publish it as an official statistic. At the time of our 
review, the Department was working with the PHA to try to resolve these issues.
5.4 Input into the SMD is voluntary, and the Department has no statutory powers to compel the 
services it funds to provide information. As a result, returns from service providers can be 
incomplete, therefore the SMD does not reflect the full extent of substance misuse treatment in 
Northern Ireland.
5.5 Whilst service providers often have their own information collection systems, these are not 
necessarily designed to collect the same information as the SMD. Service providers we spoke 
to highlighted the volume of information and returns required, and the duplication of effort 
particularly when they have multiple funders to provide information to. This puts an additional 
burden on already pressurised services.
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Recommendation 9
We recommend that the Department engage with service providers and look at best 
practice elsewhere in the UK to identify the issues that prevent data submission and work 
to ensure that comprehensive information is collected in future years.
The Impact Measurement Tool has limited coverage of substance misuse 
services
5.6 The Department also produces the Impact Measurement Tool (IMT) for substance misuse 
services in Northern Ireland. The IMT assesses the effectiveness of Tier 1 and 2 services 
funded as part of the NSD and is split into different categories, including Adult Treatment, 
Young Persons Treatment and Low Threshold Services. Information is collected pre, during, and 
post intervention and measures the impact of the service on different aspects of lifestyle and 
behaviours. The main purpose of the IMT is to inform policy makers in the Department and PHA 
about the impact alcohol and drug services had in the prior year.
5.7 Contribution to the IMT process is a contractual requirement for Tier 1 and 2 service providers, 
who are predominantly voluntary and community sector organisations. However, Tier 3 and 4 
services, which are mainly provided by the Trusts, do not contribute to the IMT. Tier 2 providers 
that we spoke to questioned the usefulness of the IMT for measuring outcomes. They told us that 
the information given back to them was nothing that they could not already produce using their 
pre-existing systems.
5.8 The Department told us that there were a number of limitations with using organisation’s own 
systems instead of regional collection. Whilst not all services collect outcome data, for those 
that do, information is limited in that it is not collected consistently across services. As such, this 
could not form a reliable, regional outcome assessment.
5.9 The latest IMT exercise covered the period from April 2016 to March 2017, however it was 
not finalised until May 2018, 14 months after the period to which it related. The stated purpose 
of the IMT is to inform policy makers of the impact of treatment services. It is unclear whether 
the information contained in the IMT remains relevant and useful to decision makers when it is 
not available until more than a year after service delivery. The Department told us that whilst 
the annual report is available within a longer timeframe, PHA has access to activity-based 
information for its commissioned services on a quarterly basis.
5.10 We reviewed the 2016-17 IMT during our audit and noted that for some services, not all 
service users had engaged for a duration or level suitable for inclusion in the IMT. The IMT is 
therefore not a comprehensive record of the number of service users seen or treated within each 
service. As both the SMD and IMT are incomplete, there is no comprehensive record of the 
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number of service users accessing substance misuse services in Northern Ireland. As a result, 
there is no way to properly plan services based on demand and the Department is unable to 
monitor outcomes at a strategic level.
Impacts could not be measured for over a third of service users on the IMT
5.11 Clients are included on the IMT based on their initial assessment by treatment services. We 
noted that for a number of service types, there was no impact recorded for a significant number 
of service users. For example, of the 936 service users attending Adult Treatment services, the 
IMT recorded the impact of treatment as “not measurable” in 513 cases. By contrast, only 
10 of the 286 service users attending Parental Substance Misuse had a status of “impact not 
measurable”.
5.12 The Department told us that it is not expected that all clients will stay for one or more reviews. 
The nature of drug and alcohol treatment with clients is that they might need to be referred 
elsewhere or disengage completely. An option exists on the IMT spreadsheet for planned or 
unplanned discharges, where agencies indicate that treatment has finished. In addition to the 
IMT, the PHA receive other monitoring reports detailing fuller activity and qualitative examples.
5.13 It is concerning that such a high proportion of service users have engaged with services, but the 
impact of this treatment was not measured. The Department highlighted this issue in the 2016-
17 IMT, advising that the significant variation across services warrants further investigation. In 
total, impact could not be measured for over 37 per cent of service users included in the IMT 
for 2016-17.
5.14 The recent review of the NSD reported that “data from the Impact Measurement Tool has been 
assessed as not quite reaching the stringent requirements for publication as an official statistic, 
which has somewhat limited our ability to see the impact and outcomes these services are 
having.” Given the significant data quality issues with both the SMD and the IMT it is not clear 
how the Department is assessing the efficiency and effectiveness of substance misuse services 
using the information it collects.
The Department has little information on the outcomes for service users 
5.15 The data that the Department currently collects on substance misuse services is largely activity 
based, recording the number of service users who enter treatment. However, the Department 
has little reliable information on the outcomes of treatment for service users.
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5.16 In our view, reliable information on outcomes is essential to ensure that the services that are 
being commissioned in Northern Ireland are effective for service users and providing value 
for money for taxpayers. Reliable outcome data will be crucial for strategy and planning 
purposes and as a result it is important that a regionally agreed, consistent approach is 
established. Whilst we acknowledge that this information can be difficult to collect, ultimately 
the Department’s data should focus on the impact services have on people’s lives rather than on 
how the services themselves are being delivered.
Recommendation 10
The new alcohol and drugs strategy should include clearly defined objectives and 
outcomes that demonstrate the effectiveness of substance misuse services and ensure that 
there are mechanisms in place to properly measure these outcomes.
There is no regional information collection on outcomes for Tier 3 and 4 
services
5.17 Tier 3 and 4 services are delivered by the Trusts in Northern Ireland. We noted that, while each 
Trust monitors the clinical outcomes of its addiction services, there is no consistent, regional 
means of data collection. The Department and the HSCB do not require statutory providers 
to report directly to them on treatment outcomes. Whilst each Trust does monitor outcomes to 
an extent, the volume, type and quality of data collected varies and there are no regionally 
determined outcome protocols. Information on what happens after referral to treatment services 
is not routinely collected. There is therefore no indication of how many of those referred to 
services actually continue on into treatment. There is also no monitoring of other outcomes such 
as employment, family relationships and social outcomes. The only targets that Trusts have in 
relation to addiction services are the ministerial waiting time targets.
5.18 In contrast, other regions in the UK collect detailed information on substance misuse services 
which is published in comprehensive substance misuse database reports (see Figure 18). 
Public Health England (PHE) publishes adult substance misuse statistics from its National Drug 
Treatment Monitoring System (NDTMS). The NDTMS collects data on treatment delivery from 
over 900 sites, covering every local authority in England. Treatment centres returning data 
include community-based and specialist outpatient drug and alcohol services, GP surgeries, 
residential rehab centres and inpatient units.
5.19 Public Health Wales and the Welsh Government publish an annual report on Treatment Data 
– Substance Misuse in Wales, containing statistics from the Welsh National Database for 
Substance Misuse (WNDSM). All substance misuse treatment service providers in Wales, in 
receipt of Welsh Government funding are required to comply with the reporting requirements of 
the database. 
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Figure 18: Substance misuse databases in England and Wales contain 
more comprehensive information26
ENGLAND WALES NORTHERN IRELAND
Number of referrals   
Demographics   
Waiting times   
Treatment/recovery outcomes   
Trends over time   
Source: Public Health England; Public Health Wales; and the Department of Health.
5.20 Tier 3 and 4 are the most expensive services to deliver, as service users are likely to have the 
most complex and severe addiction issues. However, differences in how and what services 
providers report, and problems with the existing data collection tools make it difficult for the 
Department and other statutory funders to assess the efficiency and effectiveness of these 
services. Collecting this information would also allow the Department to understand treatment 
outcomes for service users and to predict demand for services in order to inform future 
planning. In our view, it is essential that the Department puts in place a robust monitoring and 
accountability process for these services.
26  Data collection in Scotland is not on a comparable basis
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